Stresses the need to inhibit inflammatory mediators in the management of glomerular proteinuria. Examples of inflamatory mediators that must be inhibited to prevent their inadvertent activation; Circumstantial evidence that complement activation was pathogenic; Inquiry on whether complement activation occurs on normal tubules in glomerular proteinuria.